Financials

News Ideas Technicals Forecast

OSE fundamentals

Overview Statements Statistics Dividends Earnings Revenue

Key facts

—

—

—

—

—

—

—

—

About

OSE Immunotherapeutics SA s is a biotechnology company, which engages in the research and development of pharmaceutical products. It focuses on developing and partnering therapies to control the immune system for immuno-oncology and immuno-inflammation. The company was founded by Dominique Constantini on November 17, 2004 and is headquartered in Nantes, France.

Valuation

Fundamental metrics to determine fair value of the stock

Summary

No data available

There's currently no market capitalization, revenue or net income data to show.

Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

OSE does not pay dividends

The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company